Session IV:

September 30, 2026 | 1:00 – 3:30 PM EST

Clinical Trials and Access to Innovations

About the Session

Moderated by Keith Crawford, MD, PhD

Despite unprecedented advances in prostate cancer research, treatment, and precision medicine, many Black men continue to face barriers to accessing innovative therapies and participating in clinical research. Ensuring equitable access to breakthroughs requires stronger partnerships among researchers, healthcare providers, industry leaders, advocates, and the communities most affected by the disease.

Agenda: 

Welcome and Introduction: Mr. Barney Morris, PHEN Ambassador

Moderator’s Welcome: Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education, PHEN

Prostate Cancer Treatment – Progress and the Next Decade of Innovation: Richard Lee, MD, PhD, Oncologist, Mass General

Q&A: What Will Change Prostate Cancer Treatment? Drs. Keith Crawford and Richard Lee

Policy Spotlight: Modernizing Clinical Trials and Expanding Patient Access

Transition: From Policy to Innovation in Development

Five Approaches – One Goal: Industry Innovation Showcase

Live Audience Q&A: Ask the Innovators

PHEN In Memoriam Service: Rev. Adrian Backus, Director of Church Partnerships and Community Outreach, PHEN

PHEN Heroes Wall

Closing Remarks and Survey: Thomas Farrington, Founder and President, PHEN

Go to the 22nd Annual Summit Session:

THANK YOU TO OUR SPONSORS